Acetylation reprograms MITF target selectivity and residence time
- PMID: 37770430
- PMCID: PMC10539308
- DOI: 10.1038/s41467-023-41793-7
Acetylation reprograms MITF target selectivity and residence time
Abstract
The ability of transcription factors to discriminate between different classes of binding sites associated with specific biological functions underpins effective gene regulation in development and homeostasis. How this is achieved is poorly understood. The microphthalmia-associated transcription factor MITF is a lineage-survival oncogene that plays a crucial role in melanocyte development and melanoma. MITF suppresses invasion, reprograms metabolism and promotes both proliferation and differentiation. How MITF distinguishes between differentiation and proliferation-associated targets is unknown. Here we show that compared to many transcription factors MITF exhibits a very long residence time which is reduced by p300/CBP-mediated MITF acetylation at K206. While K206 acetylation also decreases genome-wide MITF DNA-binding affinity, it preferentially directs DNA binding away from differentiation-associated CATGTG motifs toward CACGTG elements. The results reveal an acetylation-mediated switch that suppresses differentiation and provides a mechanistic explanation of why a human K206Q MITF mutation is associated with Waardenburg syndrome.
© 2023. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10539308/bin/41467_2023_41793_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10539308/bin/41467_2023_41793_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10539308/bin/41467_2023_41793_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10539308/bin/41467_2023_41793_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10539308/bin/41467_2023_41793_Fig5_HTML.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10539308/bin/41467_2023_41793_Fig6_HTML.gif)
Similar articles
-
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.Int J Mol Sci. 2022 May 26;23(11):6001. doi: 10.3390/ijms23116001. Int J Mol Sci. 2022. PMID: 35682684 Free PMC article. Review.
-
Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution.Mol Cell. 2020 Aug 6;79(3):472-487.e10. doi: 10.1016/j.molcel.2020.05.025. Epub 2020 Jun 11. Mol Cell. 2020. PMID: 32531202 Free PMC article.
-
Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.Mol Cancer Ther. 2018 Dec;17(12):2543-2550. doi: 10.1158/1535-7163.MCT-18-0511. Epub 2018 Sep 28. Mol Cancer Ther. 2018. PMID: 30266801
-
BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export.Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8668-E8677. doi: 10.1073/pnas.1810498115. Epub 2018 Aug 27. Proc Natl Acad Sci U S A. 2018. PMID: 30150413 Free PMC article.
-
MITF: master regulator of melanocyte development and melanoma oncogene.Trends Mol Med. 2006 Sep;12(9):406-14. doi: 10.1016/j.molmed.2006.07.008. Epub 2006 Aug 8. Trends Mol Med. 2006. PMID: 16899407 Review.
Cited by
-
DNA damage remodels the MITF interactome to increase melanoma genomic instability.Genes Dev. 2024 Feb 13;38(1-2):70-94. doi: 10.1101/gad.350740.123. Genes Dev. 2024. PMID: 38316520 Free PMC article.
References
-
- Klemm SL, Shipony Z, Greenleaf WJ. Chromatin accessibility and the regulatory epigenome. Nat. Rev. Genet. 2019;20:207–220. - PubMed
-
- Hodgkinson CA, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 1993;74:395–404. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous